Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 61.77B | 61.77B | 61.41B | 69.63B | 52.36B | 48.33B |
Gross Profit | 22.07B | 22.07B | 19.38B | 20.66B | 21.89B | 22.16B |
EBITDA | 8.05B | 8.07B | 5.11B | 6.86B | 7.79B | 8.87B |
Net Income | 1.95B | 1.95B | -1.76B | 420.15M | 953.81M | 1.61B |
Balance Sheet | ||||||
Total Assets | 65.19B | 65.19B | 63.03B | 63.65B | 63.63B | 61.90B |
Cash, Cash Equivalents and Short-Term Investments | 8.75B | 8.75B | 7.19B | 6.97B | 6.75B | 6.33B |
Total Debt | 109.67M | 109.67M | 1.15B | 186.11M | 6.74M | 661.77M |
Total Liabilities | 13.04B | 13.04B | 13.32B | 12.51B | 12.91B | 11.62B |
Stockholders Equity | 48.83B | 48.83B | 46.44B | 47.90B | 47.51B | 47.11B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 3.64B | -252.65M | 624.80M | 2.82B | 3.25B |
Operating Cash Flow | 0.00 | 7.76B | 4.75B | 5.54B | 7.96B | 7.83B |
Investing Cash Flow | 0.00 | -4.94B | -5.06B | -4.09B | -4.97B | -8.67B |
Financing Cash Flow | 0.00 | -1.40B | 299.84M | -1.05B | -1.09B | -127.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | ¥18.00B | 7.29 | 2.15% | 5.66% | ― | ||
66 Neutral | $17.06B | 17.77 | 5.60% | 3.68% | 6.63% | 11.55% | |
― | €429.21M | 8.46 | 8.21% | ― | ― | ― | |
― | €492.89M | 11.37 | 6.08% | ― | ― | ― | |
81 Outperform | ¥59.78B | 5.39 | 2.71% | 1.12% | -3.79% | ||
73 Outperform | ¥77.62B | 10.58 | 1.42% | -2.76% | 17.20% | ||
68 Neutral | ¥37.78B | 11.08 | 1.79% | 1.39% | ― |